Contribution of Kv7.4/Kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 4, 2014, Pages 887-893

  Chadha, Preet S ^a   Jepps, Thomas A ^a   Carr, Georgina ^a   Stott, Jennifer B ^a   Zhu, Hei Lei ^b   Cole, William C ^b   Greenwood, Iain A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

calcitonin gene related peptide; cerebral arteries; inbred SHR; KCNQ; Kv7; rats; vascular; vasodilation

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; LINOPIRDINE; POTASSIUM CHANNEL KCNQ4; POTASSIUM CHANNEL KCNQ5; SMALL INTERFERING RNA;

ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BRAIN ARTERY; BRAIN CIRCULATION; BRAIN PERFUSION; BRAIN VASOSPASM; GENETIC TRANSFECTION; HYPERTENSION; LIGATION; MIDDLE CEREBRAL ARTERY; MUSCLE ISOMETRIC CONTRACTION; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; VASODILATATION;

CALCITONIN GENE-RELATED PEPTIDE; CEREBRAL ARTERIES; KCNQ; KV7; RATS, INBRED SHR; VASCULAR; VASODILATION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; KATP CHANNELS; KCNQ POTASSIUM CHANNELS; MALE; MIDDLE CEREBRAL ARTERY; POTASSIUM CHANNEL BLOCKERS; PROTEIN ISOFORMS; RATS; RATS, INBRED SHR; RATS, WISTAR; RNA INTERFERENCE; TRANSFECTION; VASODILATION; VASODILATOR AGENTS;

EID: 84897433138     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.303405     Document Type: Article

References (33)

1. Brueggemann LI, Mackie AR, Martin JL, Cribbs LL, Byron KL. Diclofenac distinguishes among homomeric and heteromeric potassium channels composed of KCNQ4 and KCNQ5 subunits. Mol Pharmacol. 2011;79:10-23.
2. Chadha PS, Zunke F, Zhu HL, Davis AJ, Jepps TA, Olesen SP, Cole WC, Moffatt JD, Greenwood IA. Reduced KCNQ4-encoded voltage-dependent potassium channel activity underlies impaired β-Adrenoceptor-mediated relaxation of renal arteries in hypertension. Hypertension. 2012;59:877-884.
3. Greenwood IA, Ohya S. New tricks for old dogs: KCNQ expression and role in smooth muscle. Br J Pharmacol. 2009;156:1196-1203.
4. Jepps TA, Chadha PS, Davis AJ, Harhun MI, Cockerill GW, Olesen SP, Hansen RS, Greenwood IA. Downregulation of Kv7.4 channel activity in primary and secondary hypertension. Circulation. 2011;124:602-611.
5. Zhong XZ, Harhun MI, Olesen SP, Ohya S, Moffatt JD, Cole WC, Greenwood IA. Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter. J Physiol. 2010;588(Pt 17):3277-3293.
6. Mani BK, Brueggemann LI, Cribbs LL, Byron KL. Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery. Br J Pharmacol. 2011;164:237-249.
7. Mani BK, O'Dowd J, Kumar L, Brueggemann LI, Ross M, Byron KL. Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm. J Cardiovasc Pharmacol. 2013;61:51-62.
8. Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004;84:903-934.
9. Edwards RM, Stack EJ, Trizna W. Calcitonin gene-related peptide stimulates adenylate cyclase and relaxes intracerebral arterioles. J Pharmacol Exp Ther. 1991;257:1020-1024.
10. Garland CJ, Yarova PL, Jiménez-Altayó F, Dora KA. Vascular hyperpo-larization to β-Adrenoceptor agonists evokes spreading dilatation in rat isolated mesenteric arteries. Br J Pharmacol. 2011;164:913-921.
11. Nelson MT, Huang Y, Brayden JE, Hescheler J, Standen NB. Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature. 1990;344:770-773.
12. Chadha PS, Zunke F, Davis AJ, Jepps TA, Linders JT, Schwake M, Towart R, Greenwood IA. Pharmacological dissection of K(v)7.1 channels in systemic and pulmonary arteries. Br J Pharmacol. 2012;166:1377-1387.
13. Khanamiri S, Soltysinska E, Jepps TA, Bentzen BH, Chadha PS, Schmitt N, Greenwood IA, Olesen S P. Contribution of Kv7 channels to basal coronary fow and active response to ischemia. Hypertension. 2013;62:1090-1097.
14. Amberg GC, Rossow CF, Navedo MF, Santana LF. NFATc3 regulates Kv2.1 expression in arterial smooth muscle. J Biol Chem. 2004;279:47326-47334.
15. Amberg GC, Santana LF. Kv2 channels oppose myogenic constriction of rat cerebral arteries. Am J Physiol Cell Physiol. 2006;291:C348-C356.
16. Tobin AA, Joseph BK, Al-Kindi HN, Albarwani S, Madden JA, Nemetz LT, Rusch NJ, Rhee SW. Loss of cerebrovascular Shaker-type K(+) channels: a shared vasodilator defect of genetic and renal hypertensive rats. Am J Physiol Heart Circ Physiol. 2009;297:H293-H303.
17. Zavaritskaya O, Zhuravleva N, Schleifenbaum J, Gloe T, Devermann L, Kluge R, Mladenov M, Frey M, Gagov H, Fésüs G, Gollasch M, Schubert R. Role of KCNQ channels in skeletal muscle arteries and periadventitial vascular dysfunction. Hypertension. 2013;61:151-159.
18. Schleifenbaum J, Köhn C, Voblova N, Dubrovska G, Zavarirskaya O, Gloe T, Crean CS, Luft FC, Huang Y, Schubert R, Gollasch M. Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfde. J Hypertens. 2010;28:1875-1882.
19. Hay DL, Poyner DR, Sexton PM. GPCR modulation by RAMPs. Pharmacol Ther. 2006;109:173-197.
20. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amy-lin, and calcitonin receptors. Pharmacol Rev. 2002;54:233-246.
21. Edvinsson L, Ekman R, Jansen I, McCulloch J, Mortensen A, Uddman R. Reduced levels of calcitonin gene-related peptide-like immunoreactivity in human brain vessels after subarachnoid haemorrhage. Neurosci Lett. 1991;121:151-154.
22. Nozaki K, Kikuchi H, Mizuno N. Changes of calcitonin gene-related peptide-like immunoreactivity in cerebrovascular nerve fbers in the dog after experimentally produced subarachnoid hemorrhage. Neurosci Lett. 1989;102:27-32.
23. Doods H, Arndt K, Rudolf K, Just S. CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci. 2007;28:580-587.
24. Kitazono T, Heistad DD, Faraci FM. Role of ATP-sensitive K+ channels in CGRP-induced dilatation of basilar artery in vivo. Am J Physiol. 1993;265(2 Pt 2):H581-H585.
25. Kleppisch T, Nelson MT. ATP-sensitive K+ currents in cerebral arterial smooth muscle: pharmacological and hormonal modulation. Am J Physiol. 1995;269(5 Pt 2):H1634-H1640.
26. Zhong XZ, Abd-Elrahman KS, Liao CH, El-Yazbi AF, Walsh EJ, Walsh MP, Cole WC. Stromatoxin-sensitive, heteromultimeric Kv2.1/Kv9.3 channels contribute to myogenic control of cerebral arterial diameter. J Physiol. 2010;588(Pt 22):4519-4537.
27. Söderberg O, Leuchowius KJ, Gullberg M, Jarvius M, Weibrecht I, Larsson LG, Landegren U. Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods. 2008;45:227-232.
28. Schwake M, Jentsch TJ, Friedrich T. A carboxy-terminal domain determines the subunit specifcity of KCNQ K+ channel assembly. EMBO Rep. 2003;4:76-81.
29. Brueggemann LI, Mackie AR, Cribbs LL, Freda J, Tripathi A, Majetschak M, Byron KL. Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels. J Biol Chem. 2014;289: 2099-2111.
30. Gustafsdottir SM, Schallmeiner E, Fredriksson S, Gullberg M, Söderberg O, Jarvius M, Jarvius J, Howell M, Landegren U. Proximity ligation assays for sensitive and specifc protein analyses. Anal Biochem. 2005;345:2-9.
31. Albarwani S, Nemetz LT, Madden JA, Tobin AA, England SK, Pratt PF, Rusch NJ. Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels. J Physiol. 2003;551(Pt 3):751-763.
32. Chen TT, Luykenaar KD, Walsh EJ, Walsh MP, Cole WC. Key role of Kv1 channels in vasoregulation. Circ Res. 2006;99:53-60.
33. Plane F, Johnson R, Kerr P, Wiehler W, Thorneloe K, Ishii K, Chen T, Cole W. Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter. Circ Res. 2005;96:216-224.